Browsing Tag
Capital Markets
26 posts
Can Christine Nelson’s promotion as CFO bring stability to NowVertical’s roadmap?
NowVertical promotes Christine Nelson to permanent CFO, signaling financial stability and capital market alignment. Find out what it means for investors.
Treasure Global executes 1-for-20 reverse stock split in last push to meet Nasdaq compliance rules
Treasure Global executes a 1-for-20 reverse stock split to regain Nasdaq bid-price compliance—read what this means for investors and future trading stability.
Marex (NASDAQ: MRX) completes Winterflood acquisition—what this means for UK equity markets
Marex completes Winterflood acquisition and announces divestment of custody arm to Epiris. Read how this reshapes UK equity market leadership.
Leadership change at Supreme Critical Metals Inc.: Glen R. Watson named CEO, George Tsafalas remains director
Supreme Critical Metals appoints Glen R. Watson as CEO to reshape its exploration strategy. Find out what this move could mean for investors and funding plans.
BlackRock–AccessFintech deal aims to streamline global post-trade operations through Aladdin integration
BlackRock deepens Aladdin integration with AccessFintech to improve real-time post-trade workflows and reduce risk across capital markets. Read more.
Cheer Holding’s delisting drama: Can the Chinese tech platform save its U.S. listing?
Cheer Holding faces Nasdaq delisting after trading below $0.10. Find out what options it has left and what investors should expect next.
Eos Energy Enterprises launches registered direct offering as it targets refinancing of 2030 convertible notes
Find out how Eos Energy Enterprises is reshaping its balance sheet with a registered direct offering and refinancing of its 2030 convertible notes.
Red Robin Gourmet Burgers launches $40m at-the-market equity program to strengthen liquidity
Find out how Red Robin Gourmet Burgers’ $40 million at-the-market equity program could reshape its balance sheet and investor sentiment today.
Shipping firm Rubico launches $7.5m offering, sparking sharp stock decline and dilution fears
Rubico Inc.’s $7.5 million underwritten offering sparked a sharp stock sell-off and raised concerns about dilution and strategy. Find out what it means for investors.
Humacyte’s $60mn funding boost sparks mixed investor reaction over equity dilution
Humacyte raises $60 million in an oversubscribed direct offering as investors debate dilution risks and long-term biotech value. Read the analysis.